show episodes
 
AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results. This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets t ...
  continue reading
 
Weekly interview show with people at the forefront of transformational technologies, scientific research, and bold new thinking that enables humans to operate at higher levels — better able to achieve whatever each person values most in life. This could be in fields as diverse as neuroscience, computer science, psychology, bio-tech, augmented reality, nutrition & fitness and so many more areas of pioneering work.
  continue reading
 
Artwork
 
Our mission is to close the gap of digital knowledge in South Africa with real conversations. We are passionate about all things and want to reach as many people as possible to spread the word. As you embark on your digital transformation journey, you need to be equipped with the right information to make the right decisions for your business as well as your clients. This podcast should enable you find the answers you have been seeking. Follow our Instagram (https://bit.ly/2LIhxez) and Linke ...
  continue reading
 
Loading …
show series
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Navid Alipour, CEO of CureMetrix, which is a leading AI-powered medical imaging company that specialises in early detection of breast cancer and heart disease. The company has received two historic FDA clearances for its AI-powered breast cancer detection and breast arterial cal…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Julien Willard, a Partner and Life Science Lead at IBM. Julien is focused on how AI is being used to tackle global health challenges, particularly in low and middle-income countries (LMICs). Julien & Andree discuss the importance of accounting for local context when implementing…
  continue reading
 
How can we effectively use large language models (LLMs) for cybersecurity tasks? In this Carnegie Mellon University Software Engineering Institute podcast, Jeff Gennari and Sam Perl discuss applications for LLMs in cybersecurity, potential challenges, and recommendations for evaluating LLMs.
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates talks to Dr Andrew Rut, CEO of Metadvice, about how AI is at the forefront of improvements to the pharmaceutical industry. Metadvice uses neural networks to enable clinicians to handle patients faster and with greater accuracy. It utilises both synthetic and real data to achieve an incredibl…
  continue reading
 
Capability-Based Planning (CBP) defines a framework that has an all-encompassing view of existing abilities and future needs for strategically deciding what is needed and how to effectively achieve it. Both business and government acquisition domains use CBP for financial success or to design a well-balanced defense system. The definitions understa…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates explores the pivotal role of AI in boosting team productivity within pharmaceutical companies, alongside Tim Cakir, CEO of TaskDrive. Tim's insights stem from his background as a growth consultant, driving TaskDrive's evolution towards AI-augmented virtual assistants and achieving remarkable…
  continue reading
 
In this episode, Dr. Andree Bates speaks with Jordan Miller, Founder of Satori, an open-source, decentralised AI prediction network. The project integrates AI and machine learning to enhance predictive capabilities. Jordan has spent the last decade building a worldwide prediction AI network and the past two years bringing it to life. His career as …
  continue reading
 
In this episode, Dr. Andree Bates speaks with Professor Shafi Ahmed and discusses how innovation and disruptive thinking can transform healthcare, making it more accessible and affordable for everyone. Professor Shafi Ahmed is a renowned surgeon and co-founder of Medical Realities, a company pioneering the use of virtual and augmented reality in me…
  continue reading
 
In this episode, Dr. Andree Bates speaks with Tristan Salomon, Founder and CEO of Axom, a company specialising in advanced AI solutions for the pharmaceutical industry. Tristan Salomon has a rich background in developing and implementing AI technologies to enhance manufacturing processes. His expertise lies in creating innovative solutions that imp…
  continue reading
 
Cybersecurity risks aren’t just a national concern. In this podcast from the Carnegie Mellon University Software Engineering Institute (SEI), the CERT division’s Tracy Bills, senior cybersecurity operations researcher and team lead, and James Lord, security operations technical manager, discuss the SEI’s work developing Computer Security Incident R…
  continue reading
 
In this episode, Dr. Andree Bates speaks with Johannes Kraus, Co-Founder of YOUTH HealthTech. As a former physical therapist Johannes experienced patients suffering and approaching him every day, barely able to treat their diseases without the ability to properly follow their prevention. He founded YOUTH to prevent diseases by focusing on early det…
  continue reading
 
Today Dr Andree Bates chats with Dr Giulio Rognini, Head of Partnerships at Metaphysiks, about how Metaphysiks is revolutionising the world of haptic feedback. Metaphysiks is leading the charge in blending human sensation with the digital realm through their innovative neuro-haptic technology. They’ve even developed the world’s first proprietary ne…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Abishek Jha, Co-Founder and CEO of Elucidata, which cleans and links biomedical data at scale. They advocate for a data-centric approach to AI, arguing that clean data is more valuable than copious data. In this episode, you will learn: How Elucidata’s sources and processes data…
  continue reading
 
Developers know that static analysis helps make code more secure. However, static analysis tools often produce a large number of false positives, hindering their usefulness. In this podcast from the Carnegie Mellon University Software Engineering Institute (SEI), David Svoboda, a software security engineer in the SEI’s CERT Division, discusses Rede…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Eric Doherty, who has worked in the pharmaceutical industry for 33 years and also in healthcare data AI for 4 years. He is the Former President of PERSOWN, Inc., a medical device company that is developing the next generation of instant Point-of-Care (POC) diagnostic testing, us…
  continue reading
 
Not all paths to cybersecurity careers look the same. In this podcast from the Carnegie Mellon University Software Engineering Institute (SEI), Randy Trzeciak, deputy director of cyber risk and resilience in the SEI’s CERT division, discusses his career journey, resources for pursuing a career in cybersecurity, and the importance of building a dive…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Philipp Lorenz, Chief Technology Officer of Basecamp Research. Basecamp Research is a market leader in mapping biodiversity for AI-based design of biological systems. They match and refine novel proteins for your exact industrial or therapeutic and diagnostic applications. In th…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Matt Van Itallie, Founder and CEO of Sema. Sema is a software company that is squarely focused on understanding and improving tech. They build tools that bring technologists and non-technologists together. They’ve successfully managed the risks of Gen AI whilst capturing the ben…
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Ben Weintraub, the President of InThought Research and Doug Foster, Creator of the inVision software. inThought Research is a leading pharmaceutical and life science consulting firm providing analytical, forecasting, and competitive intelligence services to support strategic and…
  continue reading
 
Today Dr Andree Bates talks to Patricia Gall, Founder and CEO of MindSpark 360, about the organisation's pivotal role in advancing mental health innovation. MindSpark 360 operates as a structured programme, fostering open communication among all stakeholders in the mental health sector. Whether collaborating with corporations prioritising employee …
  continue reading
 
Sam Procter started out studying computer science at the University of Nebraska, but he didn’t love it. It wasn’t until he took his first software engineering course that he knew he’d found his career path. In this podcast from the Carnegie Mellon University Software Engineering Institute, Sam Procter discusses the early influences that shaped his …
  continue reading
 
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Eunice Wu, Co-Founder and CEO of Asepha. Asepha helps Pharmacies to work efficiently and faster through specific and intelligent tests on their AI models. Eunice explains the potential of AI in revolutionising pharmacy operations and patient care, particularly through improved s…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by haemato-oncologist Niamh Boyle, who works in the Health Economic Evaluation of Precision Medicine in Cancer research project, University of South Wales. Andree and Niamh discuss the use of AI in research methodologies and processes related to precision oncology. They also talk ab…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Liam Kaufman, Vice President of Cambridge Cognition. Andree and Liam talk about the use of AI during Central Nervous System (CNS) clinical research trials. They delve into how brain health and neural pathways can be explored and analysed, solely with the use of modern scientific …
  continue reading
 
With the increasing complexity of software systems, the use of third-party components has become a widespread practice. Cyber disruptions, such as SolarWinds and Log4j, demonstrate the harm that can occur when organizations fail to manage third-party components in their software systems. In this podcast from the Carnegie Mellon University Software …
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Patrick Henz, Head of Governance, Risk and Compliance at a leading engineering and plant construction company. In this episode, Andree and Patrick discuss the relevance and implementation of AI in compliance and risk. They explore the ethics and complexities of this practice by i…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Dr Michelle Oyen, Associate Professor of Biomedical Engineering at Washington University in St.Louis. Michelle discusses the use and importance of AI in the field of maternal and fetal health. When an unexpected source changes Michelle’s career trajectory, she used her engineerin…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Hon Weng Chong, M.D., the founder of Cortical Labs. They discuss the inception of Cortical Labs and how the company is responsible for the creation of DishBrain, a powerful computational neuron system using human brain cells. Eventually, this cellular neuron system became so adap…
  continue reading
 
Across the globe, women account for less than 30 percent of professionals in technical fields. That number drops to 22 percent in the field of Artificial Intelligence (AI). In this podcast from the Carnegie Mellon University Software Engineering Institute (SEI), Violet Turri, a software developer in the SEI’s AI Division, discusses the evolution of…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Patrick Glinski and Ryan Brotman, the co-founders of Composehealth.ai. They discuss the use of artificial intelligence to automate the creation of an accurate content compliance review process, ready for use by individuals and businesses. Compose Health is an AI platform that giv…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Ari Caroline, CEO of Weave Bio, to discuss how the company is using artificial intelligence to streamline the IND application process for new therapeutics. Weave Bio has developed an AI-powered platform that aims to cut the typical four month IND drafting time in half by automati…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates speaks with Manny Nsien, MHA the CEO of Ripple Ranch, an addiction treatment centre located in Texas. They talk about how artificial intelligence can be leveraged to more precisely diagnose those suffering from addiction earlier by analysing various streams of patient data, including informat…
  continue reading
 
In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Emanuel Rose to talk about Authentic Marketing in the Age of AI. You will learn how 51% of marketers are now using AI and various ways it's being used, including for copywriting, creative support, and data analysis. Emanuel discusses using AI in marketing while maintaining authen…
  continue reading
 
At the request of the White House, the Office of the Director of National Intelligence (ODNI) began exploring use cases for large language models (LLMs) within the Intelligence Community (IC). As part of this effort, ODNI sponsored the Mayflower Project at Carnegie Mellon University’s Software Engineering Institute (SEI) from May 2023 through Septe…
  continue reading
 
Loading …

Quick Reference Guide